NCT07596875

Brief Summary

Ramadan Intermittent Fasting (RIF) is an annual fasting month from dawn to sunset, practiced by healthy Muslims. While its metabolic benefits are well studied, its effects on the gastrointestinal (GI) tract, intestinal permeability, and GI microbiota remain less explored. This study investigated the effects of RIF on gut microbiota composition and markers of intestinal permeability in two distinct populations, i.e., Italy and Lebanon. Participants from Italy and Lebanon were enrolled in this observational longitudinal study and were monitored before, during, and after RIF. Dietary intake was assessed through a validated 3-day food questionnaire before and during RIF. Blood and fecal samples were collected to analyze the markers of intestinal permeability (zonulin, lipopolysaccharide (LPS), Fatty Acid Binding Protein 2 (FABP2), and total bile acids (TBA), and gut microbiota composition using the 16S rRNA gene sequencing.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
79

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 11, 2024

Completed
29 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 9, 2024

Completed
22 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2024

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

May 12, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 19, 2026

Completed
Last Updated

June 16, 2026

Status Verified

June 1, 2026

Enrollment Period

29 days

First QC Date

May 12, 2026

Last Update Submit

June 12, 2026

Conditions

Keywords

Ramadan intermittent fastingMicrobiotaIntestinal permeability

Outcome Measures

Primary Outcomes (1)

  • Changes in Intestinal Permeability Markers

    Zonulin and LPS levels were measured through ELISA experiments where blood serum was collected from patients before and after the ending of the fasting month.

    One month

Secondary Outcomes (1)

  • Effect of RIF on Gut Microbiota Composition

    1 month

Study Arms (2)

Italian group

Muslims in Italy

Lebanese Group

Muslims in Lebanon

Eligibility Criteria

Age20 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

should be muslims in which they are able to do one month of fasting without complications

You may qualify if:

  • subjects able to provide signed consent
  • age between 20-60 years
  • Healthy Volunteers

You may not qualify if:

  • Lack of informed consent
  • pregnancy
  • celiac disease
  • diagnosis of organic diseases, cardiovascular risk
  • medications that can affect the gastrointestinal tract and interfere with symptoms

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Department of Precision and Regenerative Medicine and Ionian Area (DiMePre-J - Clinica medica "A. Murri"

Bari, BA, 70124, Italy

Location

Related Publications (2)

  • Khalil M, Abdallah H, Jaber N, Garruti G, Di Ciaula A, Portincasa P. Distinct biophysiological effects of Ramadan fasting and traditional intermittent fasting on markers of body fat storage. A real-life study. Eur J Intern Med. 2024 Nov;129:111-120. doi: 10.1016/j.ejim.2024.08.014. Epub 2024 Aug 26.

    PMID: 39191620BACKGROUND
  • Abdallah H, Khalil M, Farella I, JohnBritto JS, Lanza E, Santoro S, Garruti G, Portincasa P, Di Ciaula A, Bonfrate L. Ramadan intermittent fasting reduces visceral fat and improves gastrointestinal motility. Eur J Clin Invest. 2023 Sep;53(9):e14029. doi: 10.1111/eci.14029. Epub 2023 May 19.

    PMID: 37203871BACKGROUND

Biospecimen

Retention: SAMPLES WITHOUT DNA

blood samples were collected for intestinal permeability analysis

Study Officials

  • Piero Portincasa

    Department of Precision and Regenerative Medicine and Ionian Area (DiMePre-J) University of Bari 'Aldo Moro'

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Month
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Piero Portincasa , MD, PhD, Dr honoris. Causa ., AGAF Professor of internal medicine Chief, Clinica Medica "A. Murri" Director, Dept. Biomedical Sciences & Human Oncology

Study Record Dates

First Submitted

May 12, 2026

First Posted

May 19, 2026

Study Start

March 11, 2024

Primary Completion

April 9, 2024

Study Completion

May 1, 2024

Last Updated

June 16, 2026

Record last verified: 2026-06

Locations